Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 25th July 2019
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD provides update on veterinary medicines containing Diethanolamine
Stocks of authorised flunixin injections for non-food horses only are now available on the UK market.
Flunixin provided under ‘caution in use’ letter must cease immediately 

The Veterinary Medicines Directorate (VMD) has provided an update on medicines containing Diethanolamine (DEA), which were suspended in 2018 over concerns of a risk to humans from consuming food from animals treated with the products.

In a previous announcement, the VMD permitted supply of flunixin products (which contain DEA) for use in non-food producing horses, provided the supply was accompanied by a ‘Caution in Use’ letter for the veterinary surgeon. This was to address the potential lack of availability of flunixin for intravenous use in non-food horses

In its latest update, the VMD writes that stocks of authorised flunixin injections for non-food horses only are now available on the UK market and authorised product for food producing species (reformulated to remove diethanolamine) will shortly be available.

As such, the supply of any existing stock accompanied by a ‘Caution in Use’ letter, must now cease immediately.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.